Related Experiment Video
Updated: Jun 8, 2026
Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Factor analysis demonstrates a symptom cluster related to methane and non-methane production in irritable bowel
Marc Makhani1, Janet Yang, James Mirocha
1GI Motility Program, Division of Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Introduction:
Irritable bowel syndrome (IBS) is a chronic disorder often subdivided into constipation-predominant and diarrhea-predominant forms. Earlier studies have shown that IBS patients with methane detected on lactulose breath test (LBT) are more likely to have constipation. The goal of this study was to conduct a factor analysis to determine whether there is a cluster of symptoms associated with methane production.
Methods:
Patients with IBS referred for a LBT completed a questionnaire assessing 31 symptoms. The degree of each symptom was graded on a visual analog scale of 0 to 5. Exploratory factor analysis was carried out separately in methane and nonmethane patients. A score was determined for each symptom cluster by summing across the related variables. The cluster scores were compared between the 2 groups by the Wilcoxon rank-sum test.
Results:
A total of 459 IBS patients (72 with methane, 387 with nonmethane) were evaluated. On the basis of factor analysis results, 3 symptom clusters (bloating weighted, pain weighted, and constipation weighted) were created in methane-producing patients. Two symptom clusters (bloating weighted and diarrhea weighted) were created in the nonmethane group. The groups did not differ significantly on the methane-derived bloating score (P=0.24) or the pain score (P=0.15). However, the methane-derived constipation score was significantly higher in the methane group, 15.3 ± 4.9 versus 13.4 ± 4.9, P=0.002. The constipation-weighted cluster included the following symptoms: constipation, lack of milk intolerance, lack of weight loss, small bowel movements, and straining. The diarrhea cluster score was significantly higher in the nonmethane group, 14.2 ± 8.0 versus 11.3 ± 6.5, P=0.005. The diarrhea cluster included the following symptoms: diarrhea, pain with bowel movements, pain after bowel movements, foul-smelling bowel movements, and large bowel movements. The groups did not differ significantly on the nonmethane-derived bloating cluster, P=0.11.
Conclusions:
Methane-producing IBS patients have a unique cluster of symptoms related to constipation.
Related Concept Videos
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:23Irritable Bowel Syndrome
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:30Irritable Bowel Syndrome III: Medical and Nursing Management